vascular access devices
Conditions
Interventions
This is a randomized controlled clinical trial, single-blind, with a total sample of 330 intravenous devices, with a 1:1 ratio, where the control group will consist of 165 devices and the intervention
Sponsors
Universidade do Estado do Rio de Janeiro - UERJ
Universidade do Estado do Rio de Janeiro - UERJ
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients aged 18 years or older; of both sexes; using peripheral intravenous devices.
Exclusion criteria
Exclusion criteria: Patients with peripheral intravenous devices for surgical reasons, as it is not possible to assess adequate device patency. Patients with vasculitis, as they may present changes characteristic of the pathology, preventing adequate visualization of the venous network.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: the sample consisted of 330 devices, given that the unit presents approximately 2,320 intravenous devices annually. A sample calculation was performed with a 95% confidence level and a 5% margin of error, with the help of the website Survey Monkey®. With this, it is expected that the early identification of clinical incidents in peripheral intravenous devices identified by bedside ultrasound will minimize the severity of damage to patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is hoped that this study will show that the use of POCUS enables early identification of clinical incidents related to the use of intravenous devices. It will also enable nurses to develop a course of action to reduce complications related to incidents, ensuring vascular permeability for the individual and higher quality care in order to promote patient safety. | — |
Countries
Brazil
Contacts
Public ContactAriana Chami
Universidade do Estado do Rio de Janeiro
Outcome results
None listed